ARTICLE | Distillery Therapeutics
Autoimmune disease
August 16, 2017 6:00 PM UTC
Mouse studies suggest a CCL1-IgG fusion protein could help treat MS. The protein consists of human CCL1 fused to an IgG fragment that prolongs circulation time in mice to at least six days. In the exp...
BCIQ Company Profiles
BCIQ Target Profiles